177 related articles for article (PubMed ID: 28424404)
1. Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer.
Stewart PA; Khamis ZI; Zhau HE; Duan P; Li Q; Chung LWK; Sang QA
Oncotarget; 2017 Jun; 8(24):39209-39217. PubMed ID: 28424404
[TBL] [Abstract][Full Text] [Related]
2. Loss of SPDEF and gain of TGFBI activity after androgen deprivation therapy promote EMT and bone metastasis of prostate cancer.
Chen WY; Tsai YC; Yeh HL; Suau F; Jiang KC; Shao AN; Huang J; Liu YN
Sci Signal; 2017 Aug; 10(492):. PubMed ID: 28811384
[TBL] [Abstract][Full Text] [Related]
3. Elevated expression of minichromosome maintenance 3 indicates poor outcomes and promotes G1/S cell cycle progression, proliferation, migration and invasion in colorectal cancer.
Zhou H; Xiong Y; Zhang G; Liu Z; Li L; Hou S; Zhou T
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597491
[TBL] [Abstract][Full Text] [Related]
4. Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells.
Zhu G; Zhou J; Song W; Wu D; Dang Q; Zhang L; Li L; Wang X; He D
Oncol Rep; 2013 Aug; 30(2):904-10. PubMed ID: 23757299
[TBL] [Abstract][Full Text] [Related]
5. SATB1 promotes prostate cancer metastasis by the regulation of epithelial-mesenchymal transition.
Mao LJ; Yang CH; Fan L; Gao P; Yang DR; Xue BX; Zheng JN; Shan YX
Biomed Pharmacother; 2016 Apr; 79():1-8. PubMed ID: 27044805
[TBL] [Abstract][Full Text] [Related]
6. Studies of hormonal regulation, phenotype plasticity, bone metastasis, and experimental therapeutics in androgen-repressed human prostate cancer (ARCaP) model.
Lo UG; Chen YA; Khamis ZI; Kao WH; Hsieh JT; Sang QA
Am J Clin Exp Urol; 2021; 9(4):277-286. PubMed ID: 34541026
[TBL] [Abstract][Full Text] [Related]
7. LIV-1 promotes prostate cancer epithelial-to-mesenchymal transition and metastasis through HB-EGF shedding and EGFR-mediated ERK signaling.
Lue HW; Yang X; Wang R; Qian W; Xu RZ; Lyles R; Osunkoya AO; Zhou BP; Vessella RL; Zayzafoon M; Liu ZR; Zhau HE; Chung LW
PLoS One; 2011; 6(11):e27720. PubMed ID: 22110740
[TBL] [Abstract][Full Text] [Related]
8. Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
Cheng DD; Zhang HZ; Yuan JQ; Li SJ; Yang QC; Fan CY
Oncotarget; 2017 Apr; 8(16):26380-26393. PubMed ID: 28460433
[TBL] [Abstract][Full Text] [Related]
9. Secretome analysis reveals upregulated granzyme B in human androgen-repressed prostate cancer cells with mesenchymal and invasive phenotype.
Bou-Dargham MJ; Sang QA
PLoS One; 2020; 15(8):e0237222. PubMed ID: 32764784
[TBL] [Abstract][Full Text] [Related]
10. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
[TBL] [Abstract][Full Text] [Related]
11. Epithelial-mesenchymal-transition regulators in prostate cancer: Androgens and beyond.
Nakazawa M; Kyprianou N
J Steroid Biochem Mol Biol; 2017 Feb; 166():84-90. PubMed ID: 27189666
[TBL] [Abstract][Full Text] [Related]
12. Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells.
Qiu JX; Zhou ZW; He ZX; Zhao RJ; Zhang X; Yang L; Zhou SF; Mao ZF
Drug Des Devel Ther; 2015; 9():349-417. PubMed ID: 25609920
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer metastasis: role of the host microenvironment in promoting epithelial to mesenchymal transition and increased bone and adrenal gland metastasis.
Xu J; Wang R; Xie ZH; Odero-Marah V; Pathak S; Multani A; Chung LW; Zhau HE
Prostate; 2006 Nov; 66(15):1664-73. PubMed ID: 16902972
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition (EMT) in human prostate cancer: lessons learned from ARCaP model.
Zhau HE; Odero-Marah V; Lue HW; Nomura T; Wang R; Chu G; Liu ZR; Zhou BP; Huang WC; Chung LW
Clin Exp Metastasis; 2008; 25(6):601-10. PubMed ID: 18535913
[TBL] [Abstract][Full Text] [Related]
15. Targeting of α(v)-integrins in stem/progenitor cells and supportive microenvironment impairs bone metastasis in human prostate cancer.
van der Horst G; van den Hoogen C; Buijs JT; Cheung H; Bloys H; Pelger RC; Lorenzon G; Heckmann B; Feyen J; Pujuguet P; Blanque R; Clément-Lacroix P; van der Pluijm G
Neoplasia; 2011 Jun; 13(6):516-25. PubMed ID: 21677875
[TBL] [Abstract][Full Text] [Related]
16. Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.
Nandana S; Tripathi M; Duan P; Chu CY; Mishra R; Liu C; Jin R; Yamashita H; Zayzafoon M; Bhowmick NA; Zhau HE; Matusik RJ; Chung LW
Cancer Res; 2017 Mar; 77(6):1331-1344. PubMed ID: 28108510
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of NF-kappaB Ligand (RANKL) expression is associated with epithelial to mesenchymal transition in human prostate cancer cells.
Odero-Marah VA; Wang R; Chu G; Zayzafoon M; Xu J; Shi C; Marshall FF; Zhau HE; Chung LW
Cell Res; 2008 Aug; 18(8):858-70. PubMed ID: 18645583
[TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.
Sun Y; Wang BE; Leong KG; Yue P; Li L; Jhunjhunwala S; Chen D; Seo K; Modrusan Z; Gao WQ; Settleman J; Johnson L
Cancer Res; 2012 Jan; 72(2):527-36. PubMed ID: 22108827
[TBL] [Abstract][Full Text] [Related]
19. Do the expressions of epithelial-mesenchymal transition proteins, periostin, integrin-α4 and fibronectin correlate with clinico-pathological features and prognosis of metastatic castration-resistant prostate cancer?
Konac E; Kiliccioglu I; Sogutdelen E; Dikmen AU; Albayrak G; Bilen CY
Exp Biol Med (Maywood); 2017 Dec; 242(18):1795-1801. PubMed ID: 28836852
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics Analysis Reveals
Ma H; Liu Z; Li H; Guo X; Guo S; Qu P; Wang Y
Comput Math Methods Med; 2021; 2021():8494260. PubMed ID: 34671420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
